U.S. cannabis sales through July were a mixed bag across the country, as consumers adjusted to historic inflation and shrinking disposable income, according to an analysis of state sales data by MJBizDaily.
Cannabis consumers in Canada spent 377.5 million Canadian dollars ($290.8 million) on regulated adult-use products in June, growing 1% over May’s total to another monthly record.
New Jersey adult-use cannabis businesses recorded nearly $79.7 million in total sales between April 21 and June 30 of the state’s second fiscal quarter.
New Mexico’s cannabis market is gathering steam, with sales figures for July the strongest since the adult-use program launched in April.
Sales of legal adult-use cannabis in Canada totaled a record 375.8 million Canadian dollars ($292.1 million) in May, representing a 0.7% increase over April sales on an unadjusted basis, according to new data from Statistics Canada.
MJBizDaily tracks U.S. marijuana sales by state for recreational and medical markets that release the data.
Canadian cannabis producer Organigram trimmed its loss to 2.8 million Canadian dollars ($2.1 million) for the quarter ended May 31 on record gross revenue of CA$55.2 million.
At a little less than $38 million in June, adult-use cannabis sales in New Mexico are holding steady three months after the market launched.
Canadians bought a record 372.4 million Canadian dollars ($287 million) worth of regulated adult-use cannabis products in April, according to new data from the country’s statistics authority.
A subcommittee in Spain’s Congress of Deputies approved a draft bill to regulate some medical cannabis sales in the country, sending the proposal to the Health Commission for another key vote this week.
Two of Canada’s biggest cannabis retailers, Edmonton, Alberta-based High Tide and Toronto’s Fire & Flower, reported small losses in their latest respective quarters.
Recreational and medical cannabis sales in New Mexico topped $38.5 million in May, according to the state’s marijuana regulator.
